Clinical Trial

CleaRRAflow: Isotonic Solution vs. TPA for IVH Clearance

Name: CleaRRAflow: Isotonic Solution vs. TPA for IVH Clearance — clinical trial record (NCT07643493)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The study aims to investigate the effect of continuous tPA irrigation into the ventricles. Investigators believe it may be superior to the traditional every 8-hour bolus dosing and continuous isotonic solution irrigation alone. The protocol plans to analyze blood clearance and functional outcomes in the patients.

Trial Details

NCT Number	NCT07643493
Lead Sponsor	David Dornbos
Conditions	Tissue Plasminogen Activator, Intraventricular Brain Hemorrhage
Enrollment	80 participants
Start Date	2026-06-01
Primary Completion	2028-05-31 (estimated)
Study Completion	2029-05-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-11